StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 29 Feb 2024 08:30:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Press+Releases/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html for the full story. http://www.streetinsider.com/Globe+Newswire/Intercept+Announces+FDA+Acceptance+of+Supplemental+New+Drug+Application+for+Ocaliva%C2%AE+%28obeticholic+acid%29+for+the+Treatment+of+PBC/22858395.html Thu, 29 Feb 2024 08:30:00 -0500 A.06822034 A.23456867 ICPT ICPT ICPT O.10959959 O.20026344 O.28925957 Form 15-12G INTERCEPT PHARMACEUTICAL http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22436373.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22436373.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22436373.html Mon, 20 Nov 2023 12:10:00 -0500 ICPT O.10959959 Form 15-12G INTERCEPT PHARMACEUTICAL http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22436373.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22436373.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22436373.html Mon, 20 Nov 2023 12:10:00 -0500 ICPT O.10959959 Form EFFECT INTERCEPT PHARMACEUTICAL http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416548.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416548.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416548.html Wed, 15 Nov 2023 07:22:00 -0500 ICPT O.10959959 Form EFFECT INTERCEPT PHARMACEUTICAL http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416548.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416548.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416548.html Wed, 15 Nov 2023 07:22:00 -0500 ICPT O.10959959 Form EFFECT INTERCEPT PHARMACEUTICAL http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416155.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416155.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416155.html Wed, 15 Nov 2023 06:42:00 -0500 ICPT O.10959959 Form EFFECT INTERCEPT PHARMACEUTICAL http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416155.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416155.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416155.html Wed, 15 Nov 2023 06:42:00 -0500 ICPT O.10959959 Form EFFECT INTERCEPT PHARMACEUTICAL http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416049.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416049.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416049.html Wed, 15 Nov 2023 06:30:00 -0500 ICPT O.10959959 Form EFFECT INTERCEPT PHARMACEUTICAL http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416049.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416049.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++INTERCEPT+PHARMACEUTICAL+++++++++++++/22416049.html Wed, 15 Nov 2023 06:30:00 -0500 ICPT O.10959959 Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: AKKARAJU SRINIVAS http://www.streetinsider.com/SEC+Filings/Form++4++++++++++INTERCEPT+PHARMACEUTICAL++For%3A+Nov+08++Filed+by%3A+AKKARAJU+SRINIVAS/22401494.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++INTERCEPT+PHARMACEUTICAL++For%3A+Nov+08++Filed+by%3A+AKKARAJU+SRINIVAS/22401494.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++INTERCEPT+PHARMACEUTICAL++For%3A+Nov+08++Filed+by%3A+AKKARAJU+SRINIVAS/22401494.html Mon, 13 Nov 2023 14:52:00 -0500 ICPT O.10959959